APP下载

HMGB1与小胶质细胞在阿尔茨海默病发生发展中的研究进展

2016-10-20孔微微刘绪华

中国现代医生 2016年22期

孔微微 刘绪华 曹 红 李 军

温州医科大学附属第二医院麻醉科,浙江温州325027

HMGB1与小胶质细胞在阿尔茨海默病发生发展中的研究进展

孔微微刘绪华曹红李军▲

温州医科大学附属第二医院麻醉科,浙江温州325027

高迁移率族蛋白B1(High mobility group box protein-1,HMGB1)和小胶质细胞在阿尔茨海默病(Alzheimer's disease,AD)疾病的发生发展中起了重要的作用。HMGB1不但参与了其神经炎症的过程,并能抑制小胶质细胞对Aβ清除。通过受体结合激活了NF-κB轴信号通路的级联反应,启动基因转录和表达,释放大量炎症介质和转录产物,加重了AD的炎症反应,但有研究表明不同转录因子有不同作用,如P50敲除具有保护作用,但P65激活也具有保护作用。HMGB1通过紧密结合Aβ42,使Aβ42处于稳定的寡聚体状态,减弱小胶质细胞对Aβ42清除的能力。Aβ可直接与小胶质细胞上TLR结合,尤其是TLR2、TLR4,可以促进小胶质细胞分泌各种细胞因子和趋化因子,正反馈促进小胶质细胞的激活以及对Aβ的清除。HMGB1和小胶质细胞对Aβ清除之间失衡也是AD发生及进展的重要原因之一,因此HMGB1可能成为治疗AD的一种新的靶标。

阿尔兹海默病;β-淀粉样蛋白;小胶质细胞;高迁移率族蛋白B1

[Abstract]High mobility group protein B1(HMGB1)and microglia play an important role in Alzheimer's disease(AD)development.HMGB1 not only involve in the process of the inflammation of the nerve,and can inhibit the removal of Aβ.With combining the receptor,HMGB1 can activate a cascade of NF-κB signal pathway,promote gene transcription and expression,release lots of inflammatory mediators and transcription products,aggravate the inflammatory reaction in AD.But some studies have shown that different transcription factors have different effects,such as P50 knocked has a protective effect,but p65 activated also have a protective effect.HMGB1 tight binding of Aβ42,which make the Aβ42 in a stable state of the oligomer,weakening the ability of remove the Aβ42 in microglia.Aβ can be directly combined with TLR in microglia,especially TLR4 and TLR2,which can promote the secretion of various cytokines and chemokines,and positive feedback to promote the activation of the removal of Aβ in microglia.The imbalance between HMGB1 and microglia in Aβ clearance is one of the important reasons for the occurrence and progression of AD.Therefore,HMGB1 may be a novel therapeutic target for the treatment of AD.

[Key words]Alzheimer's disease;Beta amyloid;Microglia;High mobility group box protein-1

阿尔茨海默病(Alzheimer's disease,AD)是引起老年性痴呆的最常见原因之一,预计患病率将在2050年增加约50%[1],AD已严重影响老年人的生活质量。AD是一种中枢神经系统疾病,具有退行性、致死性、进行性发展的特点,临床表现为认知障碍和记忆功能紊乱[2],自理能力进行性减退,并伴有行为障碍和各种精神神经症状。但是迄今AD的病因和发病机制仍不清楚。……

登录APP查看全文